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The Nf2 Tumor Suppressor, Merlin, Functions
in Rac-Dependent Signaling
nervous system, particularly schwannomas and menin-
giomas (Gutmann et al., 1997). The disease is caused
by inherited mutation of the NF2 tumor suppressor gene;
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sporadically occurring tumors of these types frequentlyJohn P. O’Bryan,3 Vikas Gupta,1 Nancy Ratner,4
exhibit inactivation of both NF2 alleles. In addition, NF2Channing J. Der,3 Tyler Jacks,1
mutations are found in malignant mesotheliomas (Gu-Andrea I. McClatchey2,5
sella et al., 1999). Mice heterozygous for an Nf2 mutation1 Department of Biology and
are predisposed to developing osteosarcomas, fibrosar-Center for Cancer Research and
comas, and hepatocellular carcinomas that have lostHoward Hughes Medical Institute
the wild-type Nf2 allele. Strikingly, most tumors arisingMassachusetts Institute of Technology
in Nf2/ mice metastasize, which sharply contrasts withCambridge, Massachusetts 02139
the generally rare incidence of metastasis in the mouse.2 MGH Cancer Center and
Indeed, experimental evidence supports a role for Nf2Harvard Medical School Department of Pathology
loss in metastatic progression (McClatchey et al., 1998).Charlestown, Massachusetts 02129
The NF2-encoded protein, merlin, is highly related to3 Department of Pharmacology
the cytoskeleton:membrane linking proteins ezrin, ra-Lineberger Comprehensive Cancer Center
dixin, and moesin (the ERM proteins). Although the func-University of North Carolina at Chapel Hill
tion of the ERM proteins is not well understood, theChapel Hill, North Carolina 27599
study of merlin function has largely paralleled that of4 Department of Cell Biology, Neurobiology,
the ERMs (reviewed in Bretscher et al., 2000). There areand Anatomy
important distinctions and similarities between merlinCollege of Medicine
and the ERMs. Merlin and the ERM proteins share similarUniversity of Cincinnatti
subcellular localization to regions of dynamic cytoskele-Cincinnatti, Ohio 45267
tal remodeling such as membrane ruffles, actin-con-
taining microspikes, and the cleavage furrow (Gusella
et al., 1999). All four proteins interact with membrane-
Summary associated partners via an amino-(N)-terminal domain
and with cytoskeletal components via a carboxyl-(C)-
Mutations in the neurofibromatosis type II (NF2) tumor terminal domain (Bretscher et al., 2000). However, the
suppressor predispose humans and mice to tumor ERMs interact directly with actin via a domain that is
development. The study of Nf2/ mice has demon- not conserved in merlin. In fact, the ERM proteins are
strated an additional effect of Nf2 loss on tumor me- more closely related to each other than to merlin. Merlin
tastasis. The NF2-encoded protein, merlin, belongs to does share binding partners with the ERM proteins, in-
cluding the hyaluronic acid receptor CD44, NHE-RF/the ERM (ezrin, radixin, and moesin) family of cytoskel-
EBP50, and RhoGDI (Sainio et al., 1997; Murthy et al.,eton:membrane linkers. However, the molecular basis
1998; Maeda et al., 1999). However, the functional con-for the tumor- and metastasis- suppressing activity of
sequences of interaction of the ERMs or merlin withmerlin is unknown. We have now placed merlin in a
these proteins remains unclear.signaling pathway downstream of the small GTPase
The membrane:cytoskeletal linking activity of the ERMRac. Expression of activated Rac induces phosphory-
proteins appears to be regulated through intra- and per-lation and decreased association of merlin with the
haps intermolecular association of their N- and C-termi-cytoskeleton. Furthermore, merlin overexpression in-
nal domains (Bretscher et al., 2000). Phosphorylationhibits Rac-induced signaling in a phosphorylation-
and phospholipid binding weaken self-association ofdependent manner. Finally, Nf2/cells exhibit charac-
the ERM proteins, stimulating their ability to link mem-teristics of cells expressing activated alleles of Rac.
brane proteins and F-actin into dynamic actin structuresThese studies provide insight into the normal cellular
such as microvilli, membrane ruffles, and uropodsfunction of merlin and how Nf2 mutation contributes
(Bretscher et al., 2000). Recent studies suggest thatto tumor initiation and progression.
merlin is also regulated by self-association, and can
form homo- and heterodimers with ERM family members
Introduction (Sherman et al., 1997; Huang et al., 1998; Gronholm et
al., 1999; Nguyen et al., 2000).
Neurofibromatosis type 2 (NF2) is a familial cancer syn- Recently, we and others have shown that the small
GTPase RhoA is an important regulator of the ERM pro-drome that features the development of tumors of the
teins. The Rho family of GTPases affects reorganization
of the actin cytoskeleton and regulates such cellular
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Schorey, 1997). RhoA activity was found to be necessary02115
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residue (T558 in moesin) in the F-actin binding domain
of the ERM proteins and the subsequent formation of
ERM-containing apical microvilli (Shaw et al., 1998a;
Matsui et al., 1998; Oshiro et al., 1998). Phosphorylation
of T558 inhibits the association of the N- and C-terminal
domains of moesin in vitro, unmasking its F-actin and
membrane protein binding potential (Matsui et al., 1998;
Simons et al., 1998; Huang et al., 1999). Both Rho-kinase
and phosphatidylinositol 4-phosphate 5-kinase have
been implicated in affecting this activation of the ERM
proteins in vivo (Matsui et al., 1999). Importantly, while
the sequence surrounding this site is well conserved in
all three ERM proteins, it is quite distinct in merlin.
Merlin is also phosphorylated on serine/threonine res-
idues in response to a variety of conditions in culture
(Shaw et al., 1998b). The simplest interpretation of the
available data is that phosphorylation inactivates merlin.
High levels of a hypophosphorylated form of merlin are
associated with conditions of growth arrest by serum
deprivation, increased cell density, and loss of adhesion.
Interestingly, these are all conditions under which Rho
GTPase signaling is downregulated (Kjoller and Hall,
1999; Ren et al., 1999). Given the links between RhoA
and ERM phosphorylation, merlin phosphorylation and
growth control, and loss of merlin function leading to
metastatic tumors in mice, we have investigated
Figure 1. Activation of Rac or Cdc42, but Not Rho, Induces Merlinwhether merlin is also regulated by members of the Rho
Hyperphosphorylationfamily of GTPases. In this study, we find that merlin is
(A) Wild-type merlin was transiently transfected with or without myc-targeted by and is a regulator of the Rac/Cdc42-path-
tagged activated and dominant negative alleles of Rac, Rho, orway, providing a framework for understanding how mer-
Cdc42, as indicated, in NIH3T3 cells, then analyzed by immunoblot-
lin normally functions as a tumor and metastasis sup- ting with anti-merlin (sc331) antisera. All GTPases were expressed
pressor. in serum-starved cells. First and second lanes show merlin phos-
phorylation in cycling (ser) and serum starved (ss) cells. Equivalent
levels of activated and dominant negative GTPases were confirmedResults
by anti-myc immunoblotting (data not shown).
(B) Wild-type HA-merlin was transfected with activated Rac, immu-
Merlin Is Phosphorylated in a noprecipitated with anti-HA antisera, and treated with calf intestinal
Rac/Cdc42-Dependent Manner phosphatase (CIP), with CIP buffer alone or boiled in sample buffer
By SDS-PAGE, merlin migrates as a doublet, represent- as indicated. Merlin was detected by anti-HA immunoblotting.
(C) Wild-type merlin was transfected with Tiam1, Dbl, Lsc, or acti-ing hyper- and hypophosphorylated forms of the protein
vated Rac as indicated and analyzed as above.(Shaw et al., 1998b). Phosphoamino acid analysis and
(D) Wild-type merlin or HA-tagged Pak1 were transfected with Ractwo-dimensional phosphopeptide mapping experi-
effector mutants. Merlin was analyzed as above; Pak1 hyperphos-
ments revealed that merlin is phosphorylated at multiple phorylation resulting in a mobility shift detected by anti-HA immu-
sites, predominantly on serine residues, but also on at noblotting indicates that RacV12A37 but not RacV12C40 activates
least one threonine residue (Shaw et al., 1998b; see Pak1.
Supplemental Figure S1 at http://www.developmental.
com/cgi/content/full/1/1/63/DC1). To address whether sequential activation of Rac by Cdc42 (Nobes and Hall,
Rho GTPase activation affects merlin phosphorylation, 1995). A third merlin species with even slower mobility
NIH3T3 cells were transfected with wild-type merlin and was also noted in the presence of activated Rac or
either activated or dominant-negative alleles of the Rho Cdc42; this band may represent a super-phosphory-
family members RhoA, Rac1, and Cdc42Hs. Importantly, lated form of merlin. Phosphatase treatment of immuno-
the pattern of phosphorylation of exogenous merlin un- precipitated merlin from Rac-transfected cells demon-
der various conditions in culture is comparable to that strated that the Rac-induced mobility shift is due to
of endogenous merlin (see Figure 1A, first two lanes; phosphorylation (Figure 1B).
Shaw et al., 1998b). For example, in serum-starved cells To examine whether activation of endogenous
(Figure 1A, second lane) the ratio of the faster migrating, GTPases modulates merlin phosphorylation, merlin was
hypophosphorylated form to the hyperphosphorylated transfected with members of the Dbl family of guanine
form of exogenous merlin is high. Strikingly, while coex- nucleotide exchange factors (GEFs), each of which acti-
pression of activated Rho did not significantly affect vates a subset of Rho GTPases in vivo. For example,
merlin phosphorylation, expression of two different acti- Dbl activates Rac, Rho, and Cdc42 while Tiam-1 and
vated alleles of Rac (RacV12, RacL61) strongly in- Lsc are specific activators of Rac and Rho, respectively
creased it. An activated allele of Cdc42 (Cdc42V12) also (Van Aelst and D’Souza-Schorey, 1997). As shown in
induced merlin phosphorylation (Figure 1A), which may Figure 1C, overexpression of either Tiam-1 or Dbl in-
duced merlin phosphorylation, while expression of Lscreflect the activity of a common effector pathway or the
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of merlin (residues 1–352) migrates as a single species
(Shaw et al., 1998c); activated Rac had no additional
effect on the mobility of this fragment. In contrast, the
C-terminal half of merlin (residues 352–595) migrates as
a doublet; introduction of activated Rac increased the
amount of the upper species. Further deletion mapping
narrowed the Rac-responsive region to residues 476–
537 (Figure 2A). Orthophosphate labeling experiments
revealed that although both the N- and C-terminal halves
of merlin are phosphorylated in serum-starved cells, the
introduction of activated Rac leads to increased incor-
poration of radioactive label in the C-terminal half only
(data not shown). These data suggest that while there
may be many phosphorylation sites in merlin, the Rac-
responsive site(s) lie in the C-terminal half.
Within this region are ten serine/threonine residues,
eight of which are surrounded by consensus kinase rec-
ognition motifs (Figure 2B). Each candidate residue was
individually mutated to alanine in the context of the full-
length molecule and transfected with and without acti-
vated Rac, to determine whether loss of any one site
could affect Rac-dependent phosphorylation. As shown
in Figure 2C, conversion of T577 to alanine did not effect
basal or Rac-induced merlin phosphorylation; T577 is
analogous to T558 of moesin, which is a target of RhoA-
induced phosphorylation (Matsui et al., 1998, 1999). This
is consistent with our observation that Rho activation
Figure 2. Identification of Rac-Dependent Phosphorylation Sites had no effect on merlin phosphorylation. Instead, muta-
(A) A series of HA-tagged merlin truncations were transfected with tion of S518 had an appreciable effect on Rac-stimu-
and without activated Rac and analyzed by immunoblotting. Resi- lated phosphorylation. In fact, the S518A mutant is not
dues contained within each truncation are indicated below the cor-
phosphorylated in response to serum and migrates asresponding lanes.
a single species. Orthophosphate labeling and phos-(B) Amino acid sequence of the C-terminal half of merlin, with serine
phopeptide mapping experiments revealed that theor threonine residues matching known kinase phosphorylation mo-
tifs or conserved in Drosophila numbered above the sequence. while the S518A mutant is still phosphorylated in cells,
(C) Potential phosphorylation sites were mutated individually (or in prominent phosphopeptides are absent (see Supple-
the case of 377 and 380, in combination), to alanine in the context mental Figure S1). A synthetic peptide containing resi-
of full-length HA-tagged merlin. These constructs were then trans- due S518, but not one containing a S518A substitution,
fected with activated Rac and analyzed by immunoblotting.
can be phosphorylated in vitro in a Rac-dependent man-
ner, indicating that S518 is phosphorylated directly (J.
Kissil and T.J., unpublished data).had no effect (Figure 1C). These results suggest that
activation of endogenous Rac, and perhaps Cdc42, can
Effect of S518 Phosphorylation on Merlin Function
mediate merlin phosphorylation.
We next investigated whether Rac-induced phosphory-
Many serine/threonine kinases are known to be acti-
lation of merlin regulates its activity. Phosphorylation of
vated by Rac and/or Cdc42, and are thus candidates the ERM proteins inhibits self-association and promotes
for mediating the effect of Rac activation on merlin phos- their ability to link membrane and cytoskeletal partners.
phorylation (Aspenstrom, 1999). However, neither of two Thus, we investigated the effect of Rac-dependent
well-characterized Rac effector mutants (RacV12A37, phosphorylation on the ability of the N- and C-terminal
RacV12K40) was capable of stimulating merlin phos- halves of merlin to interact. First, the epitope-tagged,
phorylation (Figure 1D). As most known Rac effector N-terminal half of merlin was transfected into NIH3T3
pathways can be activated by one of these two effector cells together with untagged versions of either full-
mutants (Westwick et al., 1997; Lamarche et al., 1996; length merlin or the C-terminal half. Immunoprecipita-
Joneson et al., 1996), this result suggests that multiple tion of the N-terminal portion followed by immunoblot-
effector pathways are required for merlin hyperphos- ting for the C-terminal half revealed the association of
phorylation or that an uncharacterized pathway that is the two (Figure 3A). Mutation of S518 to aspartic acid,
dependent upon both amino acids 37 and 40 of Rac is which is predicted to mimic phosphoserine, inhibited the
responsible for this effect. interaction of either the full-length or C-terminal forms of
merlin with the N-terminal half. In contrast, mutation of
Identification of Rac-Induced Phosphorylation Sites S518 to alanine in the context of either the full-length
To identify Rac-induced sites of phosphorylation in mer- or C-terminal half of merlin resulted in a stronger associ-
lin, we transfected activated Rac with a series of epi- ation with the N-terminal half. These data imply that
tope-tagged merlin truncation mutants and examined the S518A mutant is not stably “closed” and therefore
their phosphorylation by electrophoretic mobility shift unavailable for interaction with the HA-N-terminal por-
tion. This idea is supported by the recent demonstration(Figure 2A). As described previously, the N-terminal half
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hyper- and hypophosphorylated merlin species were
found in the detergent insoluble fraction (Figure 3B).
When activated Rac was introduced, a significant
amount of hyperphosphorylated merlin appeared in the
soluble fraction. In contrast, activated Rac had no effect
on ezrin solubility (Figure 3B). Consistent with this obser-
vation, examination of the detergent-solubility of ex-
pressed full-length S518A and S518D mutants revealed
the relative insolubility of S518A and solubility of S518D
compared to wild-type (Figure 3C). Together, these re-
sults suggest that Rac-induced phosphorylation of mer-
lin weakens both its head-to-tail interaction and associ-
ation with the cytoskeleton.
Overexpression of Merlin Blocks Rac-Mediated
Transformation and Signaling
Overexpression of activated Rac can transform fibro-
blasts in vitro, and Rac activity is required for Ras-
induced transformation (Khosravi-Far et al., 1995; Qiu
et al., 1995). It has been previously reported that merlin
overexpression can block Ras-induced transformation
(Tikoo et al., 1994). We have confirmed this result and
also examined the ability of merlin to block Rac-induced
anchorage-independent growth in soft agar as a mea-
sure of transformation. We found that full-length merlin
efficiently inhibited Rac-induced colony formation in this
assay (Figure 4A).
We next examined the effect of merlin overexpression
on signaling pathways that are activated downstream
of Rac. A major downstream target of Rac is activation
Figure 3. Rac Regulates the Intramolecular and Cytoskeletal Asso- of the c-jun-N-terminal kinase (JNK) (Coso et al., 1995;
ciation of Merlin Minden et al., 1995). We measured the effect of merlin
(A) Untagged full-length or C-terminal merlin fragments were trans- overexpression on endogenous JNK activity by transfect-
fected with HA-tagged N-terminal merlin. Bound merlin was visual-
ing fibroblasts with full-length merlin along with a GFP-ized by immunoprecipitation with anti-HA-antisera and immunoblot-
expressing plasmid. We analyzed basal JNK activityting with anti-merlin antisera directed against the final 20 amino
specifically in the transfected cells by fluorescence-acti-acids of the protein (sc332). Five percent of the total cell extracts
were immunoblotted to confirm equivalent expression of wild-type vated cell sorting (FACS) and replating of the GFP-
and mutant merlin isoforms. Control experiments indicate that mer- expressing cells. The levels of JNK activity were mea-
lin is not nonspecifically associating with the HA-antisera or protein sured using an antibody that specifically recognizes
A beads (data not shown).
phosphorylated (active) JNK. We found that merlin over-(B) HA-tagged merlin or HA-tagged ezrin was transfected with or
expression significantly reduced the level of phosphory-without activated Rac into NIH3T3 cells, which were then serum-
lated JNK in cycling cells (Figure 4B, middle). Understarved. Triton X-100 soluble and insoluble fractions were then pre-
pared and analyzed by anti-HA immunoblotting. these conditions, merlin overexpression had a negligible
(C) Full-length wild-type, S518A- or S518D-expressing plasmids effect on the levels of phosphorylated extracellular regu-
were transfected into NIH3T3 cells in 15% serum; Triton X-100 solu- lated kinase (ERK) in these cells (Figure 4B, bottom).
ble and insoluble fractions were prepared and analyzed by immu-
A well-established consequence of JNK activation isnoblotting with an anti-merlin antibody.
increased activity of the AP-1 transcription factor, com-
posed of heterodimeric combinations of jun and fos
family members (Ip and Davis, 1998). After first ascer-that association of the N- and C-terminal halves of merlin
is a weaker and more dynamic interaction than that of taining that merlin could also specifically block Rac-
induced AP-1 activity, we asked whether this ability wasthe ERM proteins (Nguyen et al., 2000). We also exam-
ined these interactions directly by mixing 35S-labeled in dependent on merlin’s phosphorylation state (Figure
4C). Our studies of merlin phosphorylation predict thatvitro-translated versions of full-length merlin with the
HA-tagged N-terminal half of merlin and immunoprecipi- hypophosphorylated merlin is the active, tumor sup-
pressor form of the protein and that hyperphosphoryla-tating using anti-HA antisera; these experiments gave
similar results (data not shown). These data suggest tion inactivates it. To link merlin phosphorylation to its
ability to block Rac signaling, we asked whether phos-that phosphorylation of S518 disrupts merlin self-asso-
ciation, and perhaps oligomerization. phorylation-defective (S518A) or phosphorylation-mim-
icking (S518D) forms of merlin could also block Rac-Given the distinct localization of merlin to areas of
dynamic actin reorganization and its potential to interact induced signaling. Strikingly, we found that while the
S518A mutant inhibited Rac-induced activation of AP-1with membrane and cytoskeleton proteins, localization
is likely to be critical for its function. Thus, we examined reporter activity as well or better than the wild-type
protein, S518D was clearly compromised in its ability tothe effect of Rac-dependent phosphorylation on the de-
tergent-solubility of merlin. In serum-starved cells both block Rac-induced signaling relative to wild-type (Figure
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Figure 4. Merlin Inhibits Rac-Dependent
Transformation and Signaling
(A) NIH3T3 cells stably expressing activated
Rac with or without wild-type merlin were as-
sayed for their ability to proliferate under an-
chorage-independent conditions. Cells were
seeded in growth medium containing 0.3%
agar, and colonies were visualized and quan-
titated after 14 days (top). Total cell lysates
were immunoblotted using anti-merlin (sc331)
or anti-Rac antisera to ensure expression of
wild-type merlin (bottom) and Rac (data not
shown). Experiment shown is representative
of three independent experiments done in
triplicate.
(B) Immortalized fibroblasts were transfected
with a GFP-expression plasmid, with or with-
out untagged or myc-tagged wild-type mer-
lin, lacZ, or HA-tagged ezrin. GFP-positive
cells were isolated by FACS and replated in
15% serum for 24 hr prior to harvesting. Total
cell lysates were then immunoblotted with
anti-merlin (sc331), anti-phospho-JNK, anti-
phospho-ERK, or anti-JNK antibodies as indi-
cated.
(C) Cells were transfected with the AP-1 re-
porter plasmid with or without an EF1-GST-
RacV12 expression plasmid and 50 ng of
wild-type or mutant merlin expression plas-
mid, as indicated. Total cell lysates were im-
munoblotted with anti-merlin (sc331; below)
or anti-GST (not shown) antibodies.
4C). Immunoblotting confirmed that equivalent levels of To determine whether AP-1 activity was also upregu-
lated in these cells, we introduced an AP-1 luciferasewild-type and mutant merlin protein were expressed in
reporter into wild-type and Nf2/ immortalized fibro-these cells (Figure 4C). These results are consistent with
blasts. As seen in Figure 5B, basal AP-1 activity wasthe possibility that Rac-induced phosphorylation inacti-
indeed increased in Nf2/ fibroblasts. Moreover, rein-vates merlin.
troduction of Nf2 expression into Nf2/ fibroblasts re-
sulted in a dose-dependent decrease in basal AP-1 ac-
Examination of Rac-Dependent Signaling tivity to the levels of wild-type cells (Figure 5C). Taken
in Nf2-Deficient Fibroblasts together these results support the conclusion that loss
Given a link between Rac signaling and merlin phosphor- of merlin function is responsible for deregulated AP-1
ylation and regulation, we wanted to examine the integ- activity in Nf2/ cells.
rity of Rac signaling in the absence of Nf2. We previously In nearly every cell system examined, Rac plays a
generated a Nf2 mutant strain of mice and found that central role in the formation of membrane ruffles during
Nf2 homozygous mutant embryos fail at gastrulation, cell spreading, cell motility, and growth factor stimula-
precluding the isolation of embryo-derived fibroblasts tion (reviewed in Kjoller and Hall, 1999). To address the
directly (McClatchey et al., 1997). Therefore, we gener- effects of merlin deficiency on this classic cytoskeletal
ated primary Nf2/ fibroblasts from chimeric embryos response, we plated primary fibroblasts on coverslips
composed of both wild-type and Nf2/ cells (see Exper- and examined cell spreading by immunostaining for
imental Procedures). In addition, several spontaneously F-actin and the ERM proteins, which highlight the dy-
immortalized fibroblast lines were generated for each namic cortical cytoskeleton. In contrast to wild-type
genotype; these cells were used where indicated. cells, at one hour post-plating, Nf2/ cells demon-
First, we compared the levels of phosphorylated (ac- strated prominent membrane ruffles rich in F-actin and
tive) JNK in wild-type and Nf2/ fibroblasts by Western ERM proteins (Figure 6A). At this time point, wild-type
blot analysis. As shown in Figure 5A (left), we found that cells exhibited abundant apical microvilli, but few pe-
basal JNK activity was elevated approximately 4-fold in ripheral membrane ruffles. Notably, in addition to mem-
cycling Nf2/ fibroblasts and was further induced upon brane ruffles, increased vesicles are also seen in the
stimulation with serum or UV treatment. The same re- Nf2/ cells (see Figure 6A). Both of these phenotypes
sults were obtained by kinase assay (Figure 5A, right) are observed in cells overexpressing activated Rac (Van
Aelst and D’Souza-Schorey, 1997).and in Nf2/ ES cells (data not shown).
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promoting motility (Nobes and Hall, 1999). Therefore,
the behavior of Nf2-deficient cells is most consistent
with increased Rac- or Cdc42-dependent motility.
Discussion
Cloning of the NF2 gene several years ago revealed that
its encoded protein, merlin, is a member of a family of
cytoskeleton:membrane linkers whose function is not
well understood. Thus, merlin occupies an intriguing
subcellular location for a tumor suppressor. The genera-
tion and study of Nf2-mutant mice confirmed its role as
a tumor suppressor and suggested an additional role
as a metastasis suppressor (McClatchey et al., 1998).
Nevertheless, the molecular basis for the growth sup-
pressing function of merlin remains elusive. We now
provide several lines of evidence linking merlin function
to signaling by the small GTPase Rac. Given the large
body of evidence linking Rac activation to cell transfor-
mation, cell motility and invasion, these results suggest
a mechanism whereby merlin exerts its tumor and me-
Figure 5. Nf2 Deficient Fibroblasts Show Increased JNK and AP-1 tastasis suppressing activities.
Activity Our results indicate that merlin is regulated by Rac.
(A) Cycling immortalized wild-type and Nf2/ fibroblasts were stim- Although phosphopeptide mapping experiments indicate
ulated with serum or UV (80 J) for 30 min. Levels of activated JNK
that merlin phosphorylation is complex (see Supple-were evaluated by immunoblotting using an antibody that recog-
mental Figure S1), the existing data suggest that Rac-nizes phosphorylated JNK (left). The corresponding levels of total
induced phosphorylation inactivates merlin. Phosphory-JNK are shown below. In vitro kinase assay (right) yielded similarly
elevated basal JNK activity in Nf2/ cells. lation of the Rac-responsive S518 residue inhibits merlin
(B) An AP-1 luciferase reporter was transfected into wild-type and self-association, weakens its association with the cy-
Nf2/ immortalized fibroblasts and basal luciferase activity was toskeleton, and compromises its ability to inhibit Rac-
measured.
mediated signaling. This suggests that the closed or(C) The same AP-1 reporter was transfected into Nf2/ fibroblasts
oligomerized form of merlin is the active, growth sup-alone or with 50, 100, 250, or 500 ng of wild-type Nf2 expression
pressing form. This is consistent with the observationsplasmid and resulting luciferase activity was measured. The data
shown in (B) and (C) are representative of twelve independent exper- of Gutmann and colleagues, who found that the same
iments carried out using four different immortalized cell lines. amino acid residues necessary for self-association were
also required for the growth- and motility- suppressing
function of merlin in schwannoma cells (Sherman et al.,
1997; Gutmann et al., 1999). Importantly, Rac is acti-To examine whether Nf2-deficiency affected Rac-
mediated cytoskeletal changes in another setting, we vated by growth factor stimulation and matrix adhesion,
conditions which also stimulate endogenous merlin“scrape-wounded” confluent monolayers of wild-type
and Nf2/ primary fibroblasts with a plastic pipette tip phosphorylation (reviewed in Kjoller and Hall, 1999;
Shaw et al., 1998b). Our finding that merlin is phosphory-and then treated them with PDGF. As shown in Figure
6B, fifteen minutes after wounding and PDGF treatment, lated in response to activation of Rac/ Cdc42 and not
Rho would indicate that merlin and the ERMs are regu-dramatic membrane ruffling was seen at the leading
edge of the wounded Nf2/ monolayer. At this time lated in distinct ways. Together with the observation
that merlin can heterodimerize with ERM proteins (Gron-point, wild-type cells at the leading edge of the “wound”
displayed little membrane ruffling. holm et al., 1999; Huang et al., 1998), this suggests that
this family of proteins could serve to coordinate theA positive role for Rac signaling in cell motility is well
established. The link between merlin function and Rac activities of these GTPases.
The observation that merlin is phosphorylated in re-signaling together with the metastatic nature of murine
Nf2/ tumors suggested that Nf2-deficient cells may sponse to Rac activation might have suggested that
merlin is an effector of Rac and thus required for somehave enhanced motility. Thus, monolayers of wild-type
and Nf2/ MEFs growing in serum were wounded and downstream functions of Rac. Instead, our results are
consistent with a model wherein merlin normally acts tofollowed by phase contrast microscopy over the next
36 hr (Figure 6C). Strikingly, Nf2/ cells migrated to attenuate Rac signaling. First, overexpression of merlin
inhibits JNK activity as well as Rac-induced AP-1 activityclose the wound approximately two to three times as
fast as wild-type cells (15 vs 36 hr). Similarly, Nf2/ and transformation. Second, Nf2-deficient cells exhibit
phenotypes that are consistent with hyperactivation ofimmortalized fibroblasts migrate faster than wild-type
fibroblasts in transwell chamber assays (data not Rac signaling including increased activation of JNK, AP-1,
membrane ruffling, and motility. Notably, a recent studyshown). A recent analysis of the function of Rho
GTPases in wound-healing of fibroblast monolayers re- also demonstrated that overexpression of merlin inhib-
ited cell spreading and motility (Gutmann et al., 1999).vealed that while Rho activity was needed to maintain
adhesion, Rac and Cdc42 activity were more critical in Together these observations are consistent with a
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Figure 6. Nf2-Deficient Cells Exhibit In-
creased Ruffling in Response to PDGF and
Substrate Reattachment and Exhibit In-
creased Rates of Migration during Wound
Healing
(A) Serum-starved primary fibroblasts were
plated on glass coverslips and fixed 1 hr post-
plating. Cells were then processed for immu-
nocytochemistry using a pan-ERM antibody
to detect endogenous ERM protein localiza-
tion. The ERM proteins are particularly con-
centrated in membrane ruffles in the Nf2/
fibroblasts.
(B) Monolayers of wild-type and Nf2/ pri-
mary fibroblasts were wounded and treated
with 6 ng/ml PDGF. Increased protrusive ruf-
fling is observed in the Nf2/ cells.
(C) Monolayers of wild-type and Nf2/ pri-
mary fibroblasts in full serum were wounded
and examined by phase contrast microscopy
for the next 36 hr. Photos shown were taken
at the time points indicated. Nf2/ cells
closed the wound 2–3 faster than their wild-
type counterparts. Results shown are repre-
sentative of three independent experiments.
model in which merlin functions as a sensor of Rac mice develop a variety of metastatic cancers. Although
little is known about the function of Rho GTPases insignaling. Phosphorylation of merlin in response to Rac
activation or other stimuli inactivates merlin, thereby Schwann cells, human schwannoma cells exhibit actin
cytoskeleton defects consistent with increased activitypotentiating Rac signaling; dephosphorylation would re-
store its inhibitory function. This type of mechanism is of these GTPases (Pelton et al., 1998). It is well estab-
lished that Rac activity is necessary and sufficient foranalogous to the “feed-forward” mechanism of cell cy-
cle progression established via inactivation of the cell transformation of several other cell types (Zohn et al.,
1998). In addition, a large body of literature indicatescycle inhibitor p27 by cyclin-dependent kinase 2 (cdk2)-
dependent phosphorylation and subsequent degrada- that Rac activity controls cell motility and invasion. For
example, the Rac exchange factor Tiam-1 was identifiedtion (Vlach et al., 1997).
Several recent reports have demonstrated that the in a screen designed to identify genes that promote cell
invasion in vivo (Habets et al., 1994). In addition, severalERM proteins can similarly both regulate the activity of
RhoA and be regulated by phosphorylation downstream studies in normal and tumor cells have found that Rac
is a critical determinant of cell motility and invasionof RhoA. As described above, RhoA-induced phosphor-
ylation of the ERM C terminus is necessary and sufficient (Keely et al., 1997; Shaw et al., 1997; Nobes and Hall,
1999). Finally, NIH3T3 cells expressing activated Racfor the formation of apical microvilli (Matsui et al., 1999;
Oshiro et al., 1998; Shaw et al., 1998a). Conversely, a display increased metastatic potential when injected
into mice (del Peso et al., 1997).role for the ERM proteins upstream of the Rho GTPases
has emerged from several studies (Takahashi et al., The mechanism by which Rac causes transformation
or affects cell motility is not known; however, multiple1998; Lamb et al., 2000). In fact, the ERM proteins can
directly bind to RhoGDI and Dbl, negative and positive downstream targets are likely required for the full trans-
forming properties of Rac (Joneson et al., 1996; La-regulators, respectively, of Rho GTPases (Takahashi et
al., 1997, 1998). Thus the ERM proteins may serve to marche et al., 1996; Westwick et al., 1997). For example,
AP-1, a key target of Rac signaling, plays an importantlocalize regulators of the GTPases to particular sites of
action at the membrane. role in cell proliferation and cellular invasion. Known
AP-1 targets include members of the matrix metallopro-We propose that merlin functions as a tumor and me-
tastasis suppressor through its ability to inhibit Rac- teinase family, which have been repeatedly linked to the
process of tumor metastasis, suggesting a mechanismdependent signaling. Human NF2 patients are predis-
posed to developing Schwann cell tumors while Nf2/ by which Nf2 loss leads to metastatic tumor formation
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(Ip and Davis, 1998). Alternatively, Nf2 loss may alter the patients (Sebti and Hamilton, 2000). Finally, these stud-
function of its direct membrane binding partner CD44, ies also provide a broad link to the role of the mem-
whose function has been linked to metastatic progres- brane:cytoskeleton interface in tumor development and
sion of a wide variety of human tumors (Sherman et al., progression.
1994). These two hypotheses are not mutually exclusive.
Experimental ProceduresIndeed, CD44 ligation can activate Rac under certain
conditions, perhaps via direct interaction with the Rac-
Cell Culturespecific exchange factor Tiam-1 (Oliferenko et al., 2000;
NIH3T3 cells (ATCC) were grown in DMEM plus 10% calf serumBourguignon et al., 2000). Thus by directly binding CD44 (Hyclone). To generate primary Nf2/ fibroblasts, we utilized
and negatively regulating Rac signaling and AP-1 tran- lacZ;Nf2/, and lacZ;Nf2/ embryonic stem (ES) cell lines gener-
scription, merlin may be uniquely poised to negatively ated de novo from blastocysts isolated from ROSA26;Nf2/ inter-
crosses (McClatchey et al., 1997). ES cells of each genotype wereregulate tumor metastasis.
used to generate chimeric embryos by blastocyst injection. Embry-Our data do not define the mechanism by which merlin
onic fibroblasts harvested from E12.5 chimeric embryos were ex-controls Rac signaling. Extensive mutational analysis of
panded and selected in G418 (400 g/ml) to obtain pure populationsRac suggests that the downstream effector pathways
of each genotype. Each Nf2 mutant allele as well as the ROSA26
controlling cytoskeletal and transcriptional responses transgene contains a single copy of the neoR gene. Multiple ES cell
are distinct. Given that overexpression of merlin effects lines of each genotype were used for each experiment. After one
both (Figure 5, Gutmann et al., 1999), and both are dereg- passage in selection an aliquot of cells was taken for PCR analysis
and lacZ staining to determine whether selection was completeulated in Nf2-deficient cells (Figures 5 and 6), merlin
(McClatchey et al., 1997). Primary cells were used between pas-may act to modulate Rac directly, or to modulate the
sages 4 and 8. Spontaneously immortalized cells were also gener-activity of one of its enzymatic regulators. We have been
ated using the 3T9 protocol (Todaro and Green, 1963).
unable to detect appreciably elevated levels of active For wounding assays, a pipette tip (p20) was used to scrape a
Rac-GTP in Nf2/ cells by measuring the amount of monolayer wound; 6 ng/ml of PDGF was added immediately at the
(active) Rac-GTP bound to its effector Pak (data not time of wounding. For UV treatment, growing cells were treated with
80J UV-C (Stratalinker; Stratagene) after rinsing with PBS. Followingshown; Bagrodia et al., 1998; del Pozo et al., 2000). This
treatment, fresh media was placed back on the cells for the timemay be due to subtle changes in Rac activity coupled
indicated (30 min).with the relative insensitivity of this assay or to the fact
that merlin actually functions downstream of Rac as
Antibodiessuggested by the data in Figure 4. In fact, like the ERM
sc331 and sc332 antibodies (Santa Cruz) were used at 1:100 to
proteins, merlin can also bind to RhoGDI (Maeda et al., detect merlin by immunoblotting. Anti-P-JNK, P-ERK, and ERK anti-
1999). One possibility is that merlin controls the subcel- sera were all purchased from New England Biolabs and used ac-
lular localization of Rac or RhoGDI. We have not de- cording to manufacturer’s recommendations. Anti-JNK and anti-
GST antisera were purchased from Santa Cruz. Anti-HA (12CA5)tected alterations in the subcellular distribution of either
and anti-Rac antisera were purchased from Boehringer MannheimRac or RhoGDI in Nf2/ fibroblasts by crude cell frac-
and UBI, respectively. Anti-ERM antisera (CR-22) was provided bytionation; however, a higher resolution analysis is neces-
S. Tsukita.sary before this hypothesis can be ruled out.
It is likely that merlin normally controls Rac signaling
Plasmids
in a context-dependent manner, an idea that is sup- Merlin truncations were generated by PCR amplification of the spec-
ported by the relatively modest elevation of JNK activity ified coding region using oligonucleotides containing flanking Sal I
in Nf2/ cells (Figure 5A). Interestingly, a recent study restriction sites. These PCR products were ligated into the Sal I site
of the previously described HA-modified pCDNA3 or pCI-Neo (Shawdemonstrated that JNK activation by UV and serum is
et al., 1998c). Site-directed mutagenesis of merlin and Rac wasinhibited by cell confluence (Lallemand et al., 1998).
performed using the Quickchange kit (Stratagene) according toDisruption of the actin cytoskeleton reversed this effect,
manufacturer’s instruction. Each mutant was sequenced in its en-suggesting cytoskeleton-based, confluence-sensitive
tirety. pEBG-RacV12 was supplied by J. Blenis (Chou and Blenis,
regulation of JNK. Because merlin levels and phosphor- 1996). All other GTPase and merlin constructs were previously de-
ylation are also regulated by cell confluence (Shaw et scribed (Shaw et al., 1998a, c). CMV-Lsc and CMV-Dbl were supplied
al., 1998b); merlin is therefore a candidate to mediate by J. Glaven and R. Cerione (Glaven et al., 1999). CMV-Tiam1 was
supplied by C. Carpenter. CMV-HA-hPAK1 was supplied by J. Chantthis effect. In fact, we have found that Nf2/ fibroblasts
(Brown et al., 1996). AP-1 (7X), SRF, CMV-lacZ, and TK-renilla lucifer-are not contact inhibited, growing to an extremely high
ase reporters were purchased from Stratagene.saturation density and forming a multilayer rather than
a monolayer (our unpublished data).
Transcriptional ReportersThese studies suggest that the molecular basis for
Nf2-/- and wild-type immortalized cells were transiently transfected
the tumor and metastasis suppressing function of merlin using Lipofectamine Plus (LTI) according to manufacturer’s instruc-
is at least partly due to its ability to negatively regulate tions. Cells were transfected with the indicated amount of reporter,
Rac signaling. This, in turn, suggests many potential a GFP expression plasmid to monitor transfection efficiency, a TK-
renilla luciferase plasmid, and, where indicated, untagged wild-type,avenues of research and allows us to consider potential
S518A or S518D merlin, and/or GST-RacV12 expression vectors.therapeutic strategies targeted specifically to Rac sig-
Dual luciferase quantitation was determined using kits fromnaling. For example, Rac is posttranslationally modified
Promega.by geranylation (Adamson et al., 1992). Thus, by analogy
to the use of farnesyltransferase inhibitors to block post-
Indirect Immunoflourescence
translational modification of Ras, newly developed gera- Cells plated on glass coverslips were rinsed in PBS and fixed in cold
nylgeranyltransferase inhibitors may show efficacy in 3.7% paraformaldehyde for 15 min. Cells were then permeabilized in
slowing or preventing tumorigenesis and metastasis in 0.2% Triton X-100 for 10 min and processed for indirect immu-
noflourescence as previously described (Shaw et al., 1998c).Nf2/ mice, and ultimately in treating tumors in NF2
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Protein Analysis Bretscher, A., Chambers, D., Nguyen, R., and Reczek, D. (2000).
ERM-merlin and EBP50 protein families in plasma membrane orga-Total cell lysates were made by washing cells in PBS, followed by
addition of boiling SDS-lysis buffer (10 mM Tris 7.5, 1% SDS, 50 nization and function. Ann. Rev. Cell Dev. Biol. 16, 113–143.
mM NaF, 1 mM NaVO4) to the plate. Protein concentration was Brown, J.L., Stowers, L., Baer, M., Trejo, J., Coughlin, S., and Chant,
calculated using the BCA assay (Pierce) and Western analysis was J. (1996). Human Ste20 homologue hPAK1 links GTPases to the
performed as previously described (Shaw et al., 1998b). JNK, MAP kinase pathway. Curr. Biol. 6, 598–605.
Chou, M..M., and Blenis, J. (1996). The 70kDa S6 kinase complexes
Phosphorylation Analysis
with and is activated by the Rho family G proteins Cdc42 and Rac1.
NIH3T3 cells seeded at a density of 0.2  106 per 60 mm plate
Cell 85, 573–583.
were transfected using Lipofectamine Plus (LTI) according to the
Coso, O.A., Chiariello, M., Yu, J.C., Teramoto, H., Crespo, P., Xu,manufacturer’s instructions. Cells were placed in DMEM without
N., Miki, T., and Gutkind, J.S. (1995). The small GTP-binding proteinsserum 18 hr later. Six hours later, cells were washed in PBS and lysed
Rac1 and Cdc42 regulate the activity of the JNK/SAPK signalingin boiling SDS lysis buffer. Phosphatase treatment, orthophosphate
pathway. Cell 81, 1137–1146.labeling, and detergent extraction analysis were performed as pre-
viously described (Shaw et al., 1998a). del Peso, L., Hernandez-Alcoceba, R., Embade, N., Carnero, A.,
Esteve, P., Paje, C., and Lacal, J.C. (1997). Rho proteins induce
metastatic properties in vivo. Oncogene 15, 3047–3057.In Vitro Kinase Assays
Kinase assays were performed essentially as described (Hibi et del Pozo, M..A., Price, L.S., Alderson, N.B., Ren, X.D., and Schwartz,
al., 1993). Briefly, total JNK immunoprecipitated with an anti-JNK M.A. (2000). Adhesion to the extracellular matrix regulates the cou-
antibody and protein A agarose beads (Pierce) was pelleted and pling of the small GTPase Rac to its effector PAK. EMBO J. 19,
resuspended in 30 ul kinase buffer with 5 g GST-c-jun (Santa Cruz), 2008–2014.
20 l ATP, and 5 Ci [32P]ATP and incubated at 30C for 20 min.
Glaven, J.A., Whitehead, I., Bagrodia, S., Kay, R., and Cerione, R.A.Samples were resolved by SDS-PAGE, transferred to Immobilon-P
(1999). The Dbl-related protein, Lfc, localizes to microtubules and(Millipore), and subject to autoradiography.
mediates the activation of Rac signaling pathways in cells. J. Biol.
Chem. 274, 2279–2285.
Merlin Self-Association Assays
Gronholm, M., Sainio, M., Zhao, F., Heiska, L., Vaheri, A., and Carpen,NIH3T3 cells were transfected with 3 g of each construct per 60
O. (1999). Homotypic and heterotypic interaction of the neurofibro-mm plate and lysed in cold NP40 lysis buffer (50 mM Hepes [pH
matosis 2 tumor suppressor protein merlin and the ERM protein7.5], 150 mM NaCl, 1% NP40, 50 nM NaF, 0.5 mM EDTA, 1 mM
ezrin. J. Cell Sci. 112, 895–904.Pefabloc and Complete protease inhibitors [Boehringer Mannheim]).
After pelleting insoluble material, lysates were precleared for 1hr Gusella, J.F., Ramesh, V., MacCollin, M., and Jacoby, L. (1999).
with Protein A-Sepharose (PAS) beads alone. After pelleting, super- Merlin: the neurofibromatosis 2 tumor suppressor. Biochem. Bio-
natants were added to 50 l of premixed 12CA5/PAS beads and phys. Acta 1423, M29–36.
incubated at 4C for 2 hr with rocking. Bound material was pelleted Gutmann, D..H., Aylsworth, A., Carey, J.C., Korf, B., Marks, J., Pyer-
and washed 3 with NP40 lysis buffer prior to boiling in sample itz, R.E., Rubenstein, A., and Viskochil, D. (1997). The diagnostic
buffer. evaluation and multidisciplinary management of neurofibromatosis
1 and neurofibromatosis 2. JAMA 278, 51–57.
Anchorage-Independent Growth Assays
Gutmann, D..H., Sherman, L., Seftor, L., Haipek, C., Hoang Lu, K.,NIH3T3 cells transfected as described were selected in 0.4 mg/ml
and Hendrix, M. (1999). Increased expression of the NF2 tumorG418 (pCDNA3 NF2) and 0.1 mg/ml hygromycin B (pCGN Rac1L61).
suppressor gene product, merlin, impairs cell motility, adhesion andStably expressing cells were pooled and seeded at a density of
spreading. Hum. Mol. Genet. 8, 267–275.7.5  104 cells per 60 mm dish in DMEM containing 0.3% agar and
Habets, G.G., Scholtes, E.H., Zuydgeest, D., van der Kammen, R.A.,10% calf serum. Colony number was visualized after 14 days.
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